Global Cancer Nanomedicine Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 180.00 Billion |
 Market Size (Forecast Year) |
USD 445.67 Billion |
 CAGR |
% |
| Major Markets Players |
|
>全球癌症纳米药物市场，按类型（无机纳米粒子、有机纳米粒子）、药剂类型（诊断剂、治疗剂、药物输送剂）、机制（靶向肿瘤细胞、纳米载体 - 药物复合物、药物释放系统）、癌症类型（乳腺癌、胰腺癌、脑癌、肺癌、其他）、成像技术（正电子发射断层扫描、单光子发射断层扫描、磁共振成像 (MRI)）、阶段（研究、临床前、 I 期、 I/II 期、 II 期、 III 期）划分 - 行业趋势和预测到 2030 年。
癌症纳米药物市场分析及规模
根据国际癌症研究机构的数据，2020 年全球将有 1030 万人死于癌症，新增 1930 万例癌症病例。此外，预计到 2040 年，全球将有 1640 万人死于癌症相关原因，每年将有 2950 万新患者被诊断出癌症。纳米医学日益受到重视的主要原因之一是癌症和心血管疾病等慢性疾病的发病率上升。此外，由于高血压、肥胖症和其他心血管疾病患者人数增加等因素，癌症纳米医学市场正在扩大。
Data Bridge Market Research 分析，癌症纳米药物市场在 2022 年为 1800 亿美元，预计到 2030 年将达到 4456.7 亿美元，在 2023 年至 2030 年的预测期内复合年增长率为 12%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
癌症纳米药物市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021（可定制为 2015 - 2020） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
类型（无机纳米粒子、有机纳米粒子）、药剂类型（诊断剂、治疗剂、药物输送剂）、机制（靶向肿瘤细胞、纳米载体 - 药物复合物、药物释放系统）、癌症类型（乳腺癌、胰腺癌、脑癌、肺癌、其他）、成像技术（正电子发射断层扫描、单光子发射断层扫描、磁共振成像 (MRI)）、阶段（研究、临床前、I 期、I/II 期、II 期、III 期） |
|
覆盖国家 |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
Alnylam Pharmaceuticals, Inc. (U.S.), Amgen Inc. (U.S.), Arrowhead Pharmaceuticals, Inc. (U.S.), AstraZeneca (U.K.), Cadila Pharmaceuticals (India), CELGENE CORPORATION (U.S.), Celsion Corporation (U.S.), Genzyme (U.S.), Merck & Co., Inc. (U.S.), Nippon Kayaku Co.,Ltd. (Japan), Nanobiotix (France), Pfizer Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Takeda Pharmaceutical Company Limited (Japan), General Electric (U.S.), Johnson & Johnson Services, Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Gilead Sciences, Inc. (U.S.), Novartis AG (Switzerland) |
|
Market Opportunities |
|
Market Definition
Nanomedicine is a branch of nanotechnology that uses nanoparticles to diagnose, treat, monitor, and control biological systems. By manipulating materials at the nanoscale, it improves medicine delivery. As a result, nanomedicine has helped treat a wide range of diseases. Nanomedicine is still in its infancy, with numerous products in the works. Nanobiotix has identified 230 nanomedicine products that are either patented or in the early stages of development. 49 of the 230 products are on the market, while the remaining 122 are in clinical trials, either in Phase II or Phase III trials.
Global Cancer Nanomedicine Market Dynamics
Drivers
- New product launches
Nanotechnology-based liposome products may be considered one of the most advanced segments of oncology medications. For instance, Ortho Pharmaceuticals' Doxil was one of the first cancer nanomedicines approved by the US FDA in 1995 for treating AIDS-related Kaposi's sarcoma. DaunoXome by Galen Ltd is a liposomal formulation used to treat HIV-related Kaposi sarcoma, and clinical trials for this medicine in leukaemia are also being conducted. More products are in various stages of clinical trials and will be introduced into the global market in the coming years.
- Usage of nanoparticle-based imaging agents
Because of their small size, nanoparticles are easily absorbed by cells and researchers used this property to aid in disease diagnosis. Oncologists can gain a better understanding of tumour shape and size, as well as precise location, for better treatment. A few nanoparticle-based imaging agents on the market are used for Magnetic Resonance (MR) imaging. SPIO nanoparticles used in imaging include Endorem by Guerbet, Resovist by Bayer, and Feridex by Berlex Laboratories. Aside from oncology, they are also used to diagnose cardiovascular and neurological diseases, propelling the market's growth.
Opportunities
- Increasing Demand for Nanomedicines
The growing demand for nanomedicines can be attributed to the rapidly expanding applications of nanomaterials such as nanocapsules and nanotubes in drug delivery systems. The rise in cancer and cardiovascular disease incidences has boosted demand for nanomedicines, resulting in increased public and private investment in nanomedicine research and advancements in biodegradable nanoparticles. The cost-effectiveness and fewer side effects of these therapies are also major drivers of the cancer nanomedicine industry's growth.
Restraints/Challenges
- Side effects associated with the consumption of nanoparticles
The low rate of adoption, the increasing side effects associated with the consumption of nanoparticles, and the stringent regulatory framework for drug approvals are acting as market restraints for the growth of the cancer nanomedicine market during the forecast period.
This cancer nanomedicine market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cancer nanomedicine market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Cancer Nanomedicine Market
According to reports, COVID-19 positively impacts the cancer nanomedicine market. This was due to increased demand for nanomedicines to treat medical conditions similar to cancer. Furthermore, nanomedicine applications opened up new avenues for the development of innovative solutions for the prevention, detection, and treatment of viral diseases such as the COVID-19 virus, boosting the growth of the cancer nanomedicine industry. The active involvement of well-established pharmaceutical companies in the development of novel Nano science-based therapeutics is expected to influence market growth. Furthermore, advances in nanotechnology and its expanding applications in preventive interventions, early disease diagnosis, chronic and acute disorder prevention, and acute and chronic disorder prophylaxis of acute as well as chronic disorders are the factors expected to drive the cancer nanomedicine industry growth.
Recent developments
- In 2021, The national nanotechnology effort received more than USD 1.7 billion in funding from the US government, highlighting the importance of nanotechnology. Furthermore, Forbes ranks nanotechnology as the sixth most important growth technology to watch over the next ten years.
Global Cancer Nanomedicine Market Scope
The cancer nanomedicine market is segmented on the basis of type, agent type, mechanism, cancer type, imaging technique, and phase. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Inorganic Nanoparticles
- Synthesis of gold nanoparticle
- Organic Nanoparticles
- Polymeric nanoparticle
- lipid organic nanoparticles
Agent Type
- Diagnostic Agents
- Cancer biomarkers
- Diagnostic device
- Biosensors
- Microarrays
- Nanoprobes
- Quantum dots
- Therapeutic Agents
- Photodynamic therapy
- Photo thermal therapy
- Drug Delivery Agents
Mechanism
- Targeting Tumor Cells
- Passive targeting
- Active targeting
- Nanocarrier - Drug Complex
- Liposomes
- Dendrimers
- Micelles
- Inorganic nanocarriers
- Drug Release Systems
Cancer Type
- Breast Cancer
- Pancreatic Cancer
- Brain Cancer
- Lung Cancer
- Others
Imaging Technique
- Positron Emission Tomography
- Single Photon Emitted Tomography
- Magnetic Resonance Imaging (MRI)
Phase
- Research
- Preclinical
- Phase-I
- Phase-I/II
- Phase-II
- Phase-III
Cancer Nanomedicine Market Regional Analysis/Insights
The cancer nanomedicine market is analyzed and market size insights and trends are provided by country, type, agent type, mechanism, cancer type, imaging technique, and phase as referenced above.
癌症纳米药物市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
由于研发活动数量的不断增加以及各种初创企业的盛行，北美在癌症纳米医学市场占据主导地位。
由于研发活动投资水平的激增，预计亚太地区将在 2023 年至 2030 年的预测期内实现最高增长率。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和癌症纳米药物市场份额分析
癌症纳米药物市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对癌症纳米药物市场的关注有关。
癌症纳米药物市场的一些主要参与者包括：
- Alnylam Pharmaceuticals, Inc.（美国）
- 安进公司 (美国)
- Arrowhead Pharmaceuticals, Inc.（美国）
- 阿斯利康（英国）
- 卡迪拉制药（印度）
- CELGENE 公司（美国）
- Celsion Corporation（美国）
- Genzyme (美国)
- 默克公司（美国）
- 日本化药株式会社 (日本)
- Nanobiotix（法国）
- 辉瑞公司（美国）
- F. Hoffmann-La Roche Ltd（瑞士）
- 武田药品工业株式会社 (日本)
- 通用电气（美国）
- 强生服务公司（美国）
- Teva Pharmaceutical Industries Ltd.（以色列）
- 吉利德科学公司（美国）
- 诺华公司（瑞士）
研究方法：全球癌症纳米药物市场
数据收集和基准年分析是使用具有大样本量的数据收集模块进行的。市场数据使用市场统计和连贯模型进行分析和估计。市场份额分析和关键趋势分析也是市场报告中的主要成功因素。如需了解更多信息，请请求分析师致电或下拉询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，涉及数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们很自豪能够为现有和新客户提供符合其目标的数据和分析。报告可以定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（Factbook）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
